Abstract
Objectives: Acinetobacter species are one of the most frequent nosocomial pathogen and can cause a wide range of infections, including bacteremia, pneumonia, urinary tract infection, peritonitis, etc. This organism is becoming resistant to a large group of antibiotics, especially β-lactam antibiotics and also carbapenems. Aim: To determine the prevalence of Acinetobacter species in the patients of NICU and PICU of a tertiary care paediatric hospital and also to study their resistance pattern. Materials and Methods: This is a retrospective study done over a period of 12 months from January 2016 to December 2016. The Acinetobacter species isolates by all the clinical samples from NICU and PICU were identified by colony characteristics and biochemical reactions. The resistance patterns of these isolates were identified using various antibiotics by Kirby-Bauer disc diffusion test as per CLSI guidelines .Their antibiogram data and a clinical correlation was made to assess their pathogenic status and mode of acquisition. Results: Acinetobacter species was isolated in 280(30.7%) samples out of 911(17.75%) culture positive isolates from a total of 5131cultures from NICU and PICU. Maximum isolates were from Tracheal aspirate 93 (57%) followed by pus (52.71%) and blood 88(19.4%). The organism showed high rate of resistance to cefazolin (96.5%) ampicillin (91.8%), amoxyclav (85.2%) ceftriaxone (88.5%), piperacillin (82.9%), ceftazidime (77.5%), amikacin (75.2%) and ciprofloxacin (86.9%). The organism showed moderate resistance to Imipenem(68%) , meropenum (65%) and colistin (60%). Conclusion: In this study, Acinetobacter species was resistant to many drugs including imepenum and meropenum and there was a significant relationship between patients on mechanical ventilation, length of hospital stay and drug resistance.
Highlights
Hospital acquired infections are a major challenge to patient safety
Acinetobacter spp. have emerged as important organisms in intensive care units (ICUs), and this is probably related, at least in part, to the Manuscript received: 18th April 2017 Reviewed: 28th April 2017 Author Corrected: 5th May 2017 Accepted for Publication: 12th May 2017 increasingly invasive diagnostic and therapeutic procedures used in hospital ICUs in recent years[2]
The Acinetobacter species isolates by all the clinical samples from NICU and PICU patients were included in the study
Summary
Acinetobacter spp. have emerged as important organisms in intensive care units (ICUs), and this is probably related, at least in part, to the Manuscript received: 18th April 2017 Reviewed: 28th April 2017 Author Corrected: 5th May 2017 Accepted for Publication: 12th May 2017 increasingly invasive diagnostic and therapeutic procedures used in hospital ICUs in recent years[2]. Global data reveals that multidrug-resistant Acinetobacter baumannii is emerging as a common hospital-and community-acquired infection that is difficult to treat. It is a very resistant and aggressive organism that infects patients with weakened defenses like ICU patients and those with invasive devices [3]. Clinical isolates of Acinetobacter species initially retained at least partial susceptibility against the 3rd and 4th generations viz cephalosporins, fluoroquinolones, semisynthetic aminoglycosides, carbapenems and 100%
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
